NCT02884128 - A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

July 31, 2010

Conditions

Solid Tumor

Interventions

DRUG

PEP02

PEP02 was administered on Day 1. Treatment repeated every 3 weeks and it was regarded as one cycle of treatment.

DRUG

5-FU

5-FU/LV were started after the end of PEP02 infusion on Day 1 and also on Day 8. Treatment repeated every 3 weeks and it was regarded as one cycle of treatment.

DRUG

5-FU/LV were started after the end of PEP02 infusion on Day 1 and also on Day 8. Treatment repeated every 3 weeks and it was regarded as one cycle of treatment.